Barclays Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $38
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman maintains an Overweight rating on Keurig Dr Pepper (NASDAQ:KDP) and raises the price target from $36 to $38.
April 29, 2024 | 3:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays analyst Lauren Lieberman maintains an Overweight rating on Keurig Dr Pepper and raises the price target from $36 to $38.
The increase in price target by Barclays reflects a positive outlook on Keurig Dr Pepper's stock, suggesting potential upside. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100